T1FX34 Stock Overview
Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Teleflex Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$70.59 |
| 52 Week High | US$105.99 |
| 52 Week Low | US$70.59 |
| Beta | 1.17 |
| 1 Month Change | -9.86% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -50.57% |
| 5 Year Change | -50.85% |
| Change since IPO | -55.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| T1FX34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | -9.9% | -0.5% | 0.8% |
| 1Y | n/a | 2.8% | 0.8% |
Return vs Industry: Insufficient data to determine how T1FX34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how T1FX34 performed against the BR Market.
Price Volatility
| T1FX34 volatility | |
|---|---|
| T1FX34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in BR Market | 9.4% |
| 10% least volatile stocks in BR Market | 2.8% |
Stable Share Price: T1FX34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine T1FX34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 14,100 | Liam Kelly | www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Incorporated Fundamentals Summary
| T1FX34 fundamental statistics | |
|---|---|
| Market cap | R$31.26b |
| Earnings (TTM) | R$845.35m |
| Revenue (TTM) | R$17.02b |
37.0x
P/E Ratio1.8x
P/S RatioIs T1FX34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| T1FX34 income statement (TTM) | |
|---|---|
| Revenue | US$3.01b |
| Cost of Revenue | US$1.32b |
| Gross Profit | US$1.69b |
| Other Expenses | US$1.54b |
| Earnings | US$149.53m |
Last Reported Earnings
Mar 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.38 |
| Gross Margin | 55.98% |
| Net Profit Margin | 4.97% |
| Debt/Equity Ratio | 47.1% |
How did T1FX34 perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield42%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 14:30 |
| End of Day Share Price | 2025/05/05 00:00 |
| Earnings | 2025/03/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Teleflex Incorporated is covered by 35 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Matthew Taylor | Barclays |
| Craig Bijou | BofA Global Research |